PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency

Shouling Zhang, Myriam Kline, Ramsay L. Fuleihan, Usidnet Consortium, Christopher Scalchunes, Kathleen E. Sullivan, Artemio M. Jongco*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Health-related quality of life (HRQOL) is an emerging topic of interest in patients with immunodeficiency. Information about HRQOL in common variable immunodeficiency (CVID) is limited. The primary objective was to compare primary immunodeficiency disease (PIDD) patients with and without common variable immunodeficiency (CVID) on HRQOL domains using Patient-Reported Outcomes Measurement Information System (PROMIS-29) survey data from the United States Immunodeficiency Network (USIDNET) registry. The primary endpoint variables were scores on 7 HRQOL domains. The USIDNET registry was used to select patients with baseline PROMIS-29 data collected between 2015 and 2018. Descriptive statistics, Fisher’s exact test, and Student’s two-sample t test were used to compare patients with CVID versus patients with non-CVID on demographic and clinical characteristics. The single-sample t test was used to compare sample means to the normed population mean of 50. A general linear model approach to multiple regression with backward selection was used to remove factors that did not contribute significant information to the multivariable models, while controlling for multiple testing. Potential explanatory variables included group (CVID/non-CVID), sex, age, and BMI. Among 184 PIDD patients, 146 (79%) were diagnosed with CVID. Patients had a mean (SD) age of 53 (13.8), were predominantly female (83%), and were Caucasian (98%). PROMIS-29 results revealed a significant effect of group (CVID/non-CVID) on the anxiety, fatigue, and social participation domains, with fatigue being the most statistically significant. Fatigue, anxiety, and social participation may be key factors influencing HRQOL among patients with CVID. Future prospective longitudinal studies using PROMIS-29 will be needed to confirm these findings and to determine the mechanisms through which these factors develop in CVID, and how they can be improved.

Original languageEnglish (US)
Pages (from-to)379-388
Number of pages10
JournalImmunologic Research
Issue number6
StatePublished - Dec 2020
Externally publishedYes


  • CVID
  • Health-related quality of life (HRQOL)
  • PROMIS-29
  • Primary immunodeficiency

ASJC Scopus subject areas

  • Immunology


Dive into the research topics of 'PROMIS-29 survey confirms major impact of fatigue on health-related quality of life in common variable immunodeficiency'. Together they form a unique fingerprint.

Cite this